Preexposure prophylaxis, known as PrEP, reduces the risk of new HIV infections through sex by 99% and among injectable drug ...

Gilead said its fourth-quarter HIV product sales rose to $5.45 billion from $4.69 billion a year earlier, due to higher ...

Dallas, filed a bill this legislative session to prohibit insurance companies from requiring prior authorization before covering medications intended to prevent the ...

HIV affects not only your physical health but also your mental health. We reviewed online support groups for the disease, so ...

A change in Medicare policy is expected to flatten revenue from Gilead Science's HIV products, one of its most profitable segments.

Six new drugs, including a treatment for patients with advanced breast cancer, have been approved for use by the NHS in ...

Gilead Sciences posted fourth-quarter results that exceeded Wall Street expectations and forecast 2025 earnings above analyst ...

Shares of Gilead Sciences Inc. surged over 4% in premarket trading on Wednesday following a solid fourth-quarter earnings ...

In Africa, a U.S. funding loss will be critical to HIV programs in countries like Uganda, Mozambique and Tanzania.

But now, that progress is at risk. The recent pause in United States foreign assistance poses a direct threat to the lives ...

We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?

Experts assess what the freeze means for the global development sector and communities dependent on US aid, and what should ...